/uploadedImages/FACTLogo-Regular.jpgNEWS RELEASE
Issued: April 1, 2014
Contact: Linda Miller

SILVER SPRING, Md. – Progress in developing voluntary minimum standards for clinical and laboratory practice in regenerative medicine and related cellular therapies has been presented at an FDA workshop by the Foundation for the Accreditation of Cellular Therapy (FACT). “In April we will be publishing draft standards that encompass all phases of cellular therapy including cell collection, laboratory processing and patient care,” said Carolyn Keever-Taylor, PhD, Vice President of the FACT Board of Directors who presented on behalf of the organization.
“The draft is based on FACT’s 18 years of experience in cellular therapy standards development and accreditation.” The draft standards, scheduled for 90 days of public comment beginning April 30, will be a major step toward voluntary accreditation, she said. “We welcome health professionals, representatives of industry and the general public to submit comments, all of which will be carefully considered as we complete work on the standards.”
Read full release

Ask FACT

FAQ

FACT Consulting

Accreditation Success Story

Hospital Israelita Albert Einstein (HIAE) in Brazil is the first Bone Marrow Transplantation Center in Latin America to receive FACT accreditation. HIAE is accredited for autologous and allogenic transplantation. Read more